Reply to letter to the editor: baricitinib and toxicity is a rare occurrence

Expert Opin Drug Saf. 2020 Oct;19(10):1371-1372. doi: 10.1080/14740338.2020.1812192. Epub 2020 Aug 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Azetidines
  • COVID-19 Drug Treatment*
  • Humans
  • Janus Kinase Inhibitors*
  • Liver
  • Purines
  • Pyrazoles
  • SARS-CoV-2
  • Sulfonamides

Substances

  • Azetidines
  • Janus Kinase Inhibitors
  • Purines
  • Pyrazoles
  • Sulfonamides
  • baricitinib